|
|
|
|
|
by makomk
2830 days ago
|
|
The cheaper alternative that the NHS wants to offer is not actually the same as the more expensive drug that's licensed to treat wet age-related macular degeneration. It's related and there's every reason to believe it's as safe and effective as the licensed drug, but it's still not the same stuff. |
|
I expect that the price of the other two will mysteriously drop quite dramatically now ...